Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADMA 28 in coronary artery disease
NCT01581034Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Apr 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PADMA 28 in coronary artery disease (CAD), sponsored by Insel Gruppe. Started Apr 2012; status: completed.
02
Drugs
PADMA 28
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01581034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581034.